Pulmonx Share Price (NASDAQ: LUNG)
$1.71
Last updated on
Check the interactive Pulmonx Stock chart to analyse performance
Pulmonx stock performance
as on August 30, 2025 at 1:29 am IST
- Today's Low:$1.71Today's High:$1.77
0.29%
Downside
Day's Volatility :3.4%
Upside
3.12%
- 52 Weeks Low:$1.4752 Weeks High:$9.37
14.04%
Downside
52 Weeks Volatility :84.31%
Upside
81.75%
Pulmonx Stock Returns
Pulmonx Corp Key Stats
Check Pulmonx key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.
Stock Returns calculator for Pulmonx Stock including INR - Dollar returns
The Pulmonx stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Pulmonx investment value today
Current value as on today
₹31,592
Returns
Returns from Pulmonx Stock
Dollar Returns*
₹5,284 (+5.28%)
Indian investors sentiment towards Pulmonx Stock
Global Institutional Holdings in Pulmonx Corp
Name
Holdings %
FMR Inc
13.30%
PRIMECAP Management Company
12.68%
Morgan Stanley - Brokerage Accounts
8.58%
BlackRock Inc
6.84%
Vanguard Group Inc
5.63%
Deerfield Management Co
4.64%
Analyst Recommendation on Pulmonx Stock
Buy
81%Buy
18%Hold
0%Sell
Based on 11 Wall street analysts offering stock ratings for Pulmonx(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Pulmonx Share Price Target
What analysts predicted
Upside of 294.74%
Target:
$6.75
Current:
$1.71
Pulmonx share price target is $6.75, a slight Upside of 294.74% compared to current price of $1.71 as per analysts' prediction.
Pulmonx Stock Insights
Price Movement
In the last 3 months, LUNG stock has moved down by -49.9%Increasing Revenue
Revenue is up for the last 2 quarters, 22.53M → 23.85M (in $), with an average increase of 5.5% per quarterDecreasing Net Profit
Netprofit is down for the last 3 quarters, -13.17M → -15.17M (in $), with an average decrease of 7.3% per quarterLUNG vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 29.0% return, outperforming this stock by 105.7%LUNG vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 161.7% return, outperforming this stock by 252.4%Price to Sales
ForLUNG every $1 of sales, investors are willing to pay $0.7, whereas for Boston Scientific Corp., the investors are paying $8.4 for every $1 of sales.
Pulmonx Corp Financials
Pulmonx Technicals Summary
Sell
Neutral
Buy
Pulmonx is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Pulmonx Corp Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| 5.9% | -79.43% | -73.77% | -90.78% | -95.66% |
 | 3.87% | -1.59% | 4.32% | 4.82% | -13.69% |
 | 2.55% | 13.95% | 18.33% | -9.73% | -5.31% |
 | 0.09% | 0.6% | 30.02% | 157.38% | 154.4% |
 | 3.63% | -0.85% | 8.87% | 89.43% | 97.71% |
 | 4.24% | -5.37% | 15.72% | 26.56% | 24.53% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| NA | NA | NA | -1.55 | -0.67 | -0.22 | NA | 1.7 |
| 25.4 | 25.4 | 2.14 | 5.46 | 0.1 | 0.05 | 0.03 | 37.36 |
| 34.03 | 34.03 | 4.85 | 2.5 | 0.16 | 0.08 | NA | 17.94 |
| 62.95 | 62.95 | 1.84 | 2.98 | 0.12 | 0.05 | NA | 15.14 |
| 51.54 | 51.54 | 2.24 | 13.49 | 0.14 | 0.08 | 0.01 | 55.43 |
| 16.64 | 16.64 | 4.17 | 5.14 | 0.31 | 0.07 | 0.02 | 29.05 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Buy | $71.7M | -95.66% | NA | -62.88% |
| Buy | $118.0B | -13.69% | 25.4 | 13.63% |
| Buy | $47.8B | -5.31% | 34.03 | 72.96% |
| Buy | $156.7B | 154.4% | 62.95 | 13.55% |
| Buy | $149.0B | 97.71% | 51.54 | 12.25% |
| Buy | $230.9B | 24.53% | 16.64 | 32.43% |
About Pulmonx Corp
Key Management of Pulmonx Corp
Important FAQs about investing in LUNG Stock from India :
What is Pulmonx share price today?
Pulmonx share price today is $1.71 as on at the close of the market. Pulmonx share today touched a day high of $1.77 and a low of $1.71.
What is the 52 week high and 52 week low for Pulmonx share?
Pulmonx share touched a 52 week high of $9.37 and a 52 week low of $1.47. Pulmonx stock price today i.e. is closed at $1.71, lower by 81.75% versus the 52 week high.
How to invest in Pulmonx Stock (LUNG) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Pulmonx on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Pulmonx Shares that will get you 0.8772 shares as per Pulmonx share price of $1.71 per share as on August 30, 2025 at 1:29 am IST.
What is the minimum amount required to buy Pulmonx Stock (LUNG) from India?
Indian investors can start investing in Pulmonx (LUNG) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Pulmonx stock (as per the Rupee-Dollar exchange rate as on August 31, 2025).
Based on Pulmonx share’s latest price of $1.71 as on August 30, 2025 at 1:29 am IST, you will get 5.8480 shares of Pulmonx. Learn more about
fractional shares .
What are the returns that Pulmonx has given to Indian investors in the last 5 years?
Pulmonx stock has given -95.66% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?
Discover More
Webs Defined Volatility Xle$24.99
-0.04%
- United States 12 Month Natur
$7.81
+1.83%
- F/m U S T Inl-p S (tips) Etf
$50.14
+0.06%
- Pgim Jennison Focused Growth Etf
$105.89
-1.37%
Hitek Global Inc$1.49
+1.36%
Vaneck Vectors Preferred Secs Ex Finls Etf$17.68
-0.73%
Marker Therapeutics Inc$0.93
+3.33%
Grupo Aval Acciones Y Valores S.a.$3.33
-0.89%